Dr. Michael Lipscomb, a new faculty member in the Dept of Pharmacology brings his expertise and an R35 MIRA award to his research into mechanistically describing the immunoregulatory network(s) that govern the differentiation and function of antigen-presenting myeloid cells. His goal is to translate this work into better patient therapies.
|
|
